Broadfin Capital, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2019$3,451,000
-82.5%
30,000
-82.9%
0.64%
-79.2%
Q1 2018$19,721,000
+21.5%
175,030
+42.4%
3.07%
+15.8%
Q4 2017$16,228,000
+184.7%
122,930
-63.1%
2.65%
+162.2%
Q3 2013$5,700,000
+131.0%
332,936
+18.9%
1.01%
+109.5%
Q2 2013$2,467,000280,0000.48%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders